Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 107

1.

Long-term results and PSA kinetics after robotic SBRT for prostate cancer: multicenter retrospective study in Korea (Korean radiation oncology group study 15-01).

Park Y, Park HJ, Jang WI, Jeong BK, Kim HJ, Chang AR.

Radiat Oncol. 2018 Nov 23;13(1):230. doi: 10.1186/s13014-018-1182-z.

2.

Prostate specific antigen kinetics following robotic stereotactic body radiotherapy for localized prostate cancer.

Kole TP, Chen LN, Obayomi-Davies O, Kim JS, Lei S, Suy S, Dritschilo A, Collins SP.

Acta Oncol. 2015 Jun;54(6):832-8. doi: 10.3109/0284186X.2014.983656. Epub 2014 Dec 3.

PMID:
25467965
3.
4.

Stereotactic body radiation therapy (SBRT) for clinically localized prostate cancer: the Georgetown University experience.

Chen LN, Suy S, Uhm S, Oermann EK, Ju AW, Chen V, Hanscom HN, Laing S, Kim JS, Lei S, Batipps GP, Kowalczyk K, Bandi G, Pahira J, McGeagh KG, Collins BT, Krishnan P, Dawson NA, Taylor KL, Dritschilo A, Lynch JH, Collins SP.

Radiat Oncol. 2013 Mar 13;8:58. doi: 10.1186/1748-717X-8-58.

5.

Hypofractionated SBRT versus conventionally fractionated EBRT for prostate cancer: comparison of PSA slope and nadir.

Anwar M, Weinberg V, Chang AJ, Hsu IC, Roach M 3rd, Gottschalk A.

Radiat Oncol. 2014 Feb 2;9:42. doi: 10.1186/1748-717X-9-42.

6.
7.

Stereotactic body radiotherapy for localized prostate cancer: interim results of a prospective phase II clinical trial.

King CR, Brooks JD, Gill H, Pawlicki T, Cotrutz C, Presti JC Jr.

Int J Radiat Oncol Biol Phys. 2009 Mar 15;73(4):1043-8. doi: 10.1016/j.ijrobp.2008.05.059. Epub 2008 Aug 26.

PMID:
18755555
8.

High-Dose Robotic Stereotactic Body Radiotherapy in the Treatment of Patients With Prostate Cancer: Preliminary Results in 26 Patients.

Pontoriero A, Iatì G, Mondello S, Midili F, Siragusa C, Brogna A, Ielo I, Anastasi G, Magno C, Pergolizzi S, De Renzis C.

Technol Cancer Res Treat. 2016 Feb;15(1):179-85. doi: 10.1177/1533034614566994. Epub 2015 Jan 13.

PMID:
25586517
9.

A single-center study of 100 consecutive patients with localized prostate cancer treated with stereotactic body radiotherapy.

Bolzicco G, Favretto MS, Satariano N, Scremin E, Tambone C, Tasca A.

BMC Urol. 2013 Oct 17;13:49. doi: 10.1186/1471-2490-13-49.

10.

Stereotactic body radiation therapy (SBRT) for prostate cancer in men with large prostates (≥50 cm(3)).

Janowski E, Chen LN, Kim JS, Lei S, Suy S, Collins B, Lynch J, Dritschilo A, Collins S.

Radiat Oncol. 2014 Nov 15;9:241. doi: 10.1186/s13014-014-0241-3.

11.

Stereotactic body radiotherapy as boost for organ-confined prostate cancer.

Katz AJ, Santoro M, Ashley R, Diblasio F, Witten M.

Technol Cancer Res Treat. 2010 Dec;9(6):575-82.

PMID:
21070079
12.

Clinical outcomes of whole pelvis radiotherapy and stereotactic body radiotherapy boost for intermediate- and high-risk prostate cancer.

Kim HJ, Phak JH, Kim WC.

Asia Pac J Clin Oncol. 2017 Oct;13(5):e342-e347. doi: 10.1111/ajco.12455. Epub 2016 Feb 5.

PMID:
26846353
13.

Stereotactic body radiotherapy for localized prostate cancer: disease control and quality of life at 6 years.

Katz AJ, Santoro M, Diblasio F, Ashley R.

Radiat Oncol. 2013 May 13;8:118. doi: 10.1186/1748-717X-8-118.

14.

Stereotactic body radiotherapy as monotherapy or post-external beam radiotherapy boost for prostate cancer: technique, early toxicity, and PSA response.

Jabbari S, Weinberg VK, Kaprealian T, Hsu IC, Ma L, Chuang C, Descovich M, Shiao S, Shinohara K, Roach M 3rd, Gottschalk AR.

Int J Radiat Oncol Biol Phys. 2012 Jan 1;82(1):228-34. doi: 10.1016/j.ijrobp.2010.10.026. Epub 2010 Dec 22.

PMID:
21183287
16.

Stereotactic body radiotherapy for prostate cancer: a preliminary report.

Lee YH, Son SH, Yoon SC, Yu M, Choi BO, Kim YS, Jang HS, Lee SN, Jang JS, Hwang TK.

Asia Pac J Clin Oncol. 2014 Jun;10(2):e46-53. doi: 10.1111/j.1743-7563.2012.01589.x. Epub 2012 Sep 20.

PMID:
22994564
17.
18.

Multicenter Trial of Stereotactic Body Radiation Therapy for Low- and Intermediate-Risk Prostate Cancer: Survival and Toxicity Endpoints.

Meier RM, Bloch DA, Cotrutz C, Beckman AC, Henning GT, Woodhouse SA, Williamson SK, Mohideen N, Dombrowski JJ, Hong RL, Brachman DG, Linson PW, Kaplan ID.

Int J Radiat Oncol Biol Phys. 2018 Oct 1;102(2):296-303. doi: 10.1016/j.ijrobp.2018.05.040. Epub 2018 Jun 1.

19.

Image-guided stereotactic body radiation therapy for clinically localized prostate cancer: preliminary clinical results.

Bolzicco G, Favretto MS, Scremin E, Tambone C, Tasca A, Guglielmi R.

Technol Cancer Res Treat. 2010 Oct;9(5):473-7.

PMID:
20815418
20.

Early and multiple PSA bounces can occur following high-dose prostate stereotactic body radiation therapy: Subset analysis of a phase 1/2 trial.

Kim DN, Straka C, Cho LC, Lotan Y, Yan J, Kavanagh B, Raben D, Cooley S, Brindle J, Xie XJ, Pistenmaa D, Timmerman R.

Pract Radiat Oncol. 2017 Jan - Feb;7(1):e43-e49. doi: 10.1016/j.prro.2016.06.010. Epub 2016 Jun 24.

PMID:
27637137

Supplemental Content

Support Center